CRVS stock
Corvus Pharmaceuticals Inc [CRVS] Stock sold by Insider ORBIMED ADVISORS LLC for $4.89 million
Corvus Pharmaceuticals Inc’s filing revealed that its Director ORBIMED ADVISORS LLC unloaded Company’s shares for reported $4.89 million on Jun ...
Recent Insider Activity Could Benefit Corvus Pharmaceuticals Inc (CRVS)
In a filing, Corvus Pharmaceuticals Inc revealed its Director ORBIMED ADVISORS LLC unloaded Company’s shares for reported $4.89 million on ...
Checking in on Corvus Pharmaceuticals Inc (CRVS) after recent insiders movement
In a filing, Corvus Pharmaceuticals Inc revealed its Director ORBIMED ADVISORS LLC unloaded Company’s shares for reported $4.89 million on ...
Corvus Pharmaceuticals Inc [CRVS] Investment Appeal on the Rise
Corvus Pharmaceuticals Inc’s recently made public that its Director ORBIMED ADVISORS LLC unloaded Company’s shares for reported $4.89 million on ...
CRVS stock rated an Overweight by Barclays
Corvus Pharmaceuticals Inc’s filing revealed that its Director ORBIMED ADVISORS LLC unloaded Company’s shares for reported $4.89 million on Jun ...
Taking a Closer Look At Corvus Pharmaceuticals Inc (CRVS) Following Its Recent Trade
Corvus Pharmaceuticals Inc’s recent filing unveils that its Director ORBIMED ADVISORS LLC unloaded Company’s shares for reported $4.89 million on ...
Keeping an Eye on Corvus Pharmaceuticals Inc (CRVS) After Insider Trading Activity
Corvus Pharmaceuticals Inc’s filing revealed that its Director ORBIMED ADVISORS LLC unloaded Company’s shares for reported $4.89 million on Jun ...
